Fundraising Fox

Orbital Therapeutics

5 known investors

orbitaltx.com ↗

A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.

BiotechHealthtechMedical Devicesin /bristol-myers-squibb@BMSNEWS

Investors · 5

Andreessen HorowitzMenlo Park · $500K – $50M
ARCH Venture PartnersChicago · $50K – $250M
iGlobe PartnersSingapore · $600K – $6M
Agent CapitalreportedWaltham
Newpath Partnersreported · 2 sourcesBoston · $50K – $10M

In the news